Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration
Title:
Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration
Author:
Eichenbaum, David A. Holekamp, Nancy Khanani, Arshad M. Pieramici, Dante Hershberger, Vrinda Sheth, Veeral Brunstein, Flavia Ma, Ling Zou, Yixuan Indjeian, Vahan B. Dere, Randall Maia, Mauricio Hsu, Joy C. Gao, Simon S. Yaspan, Brian Willis, Jeffrey R. Wiley, Henry Lai, Phillip Chen, Hao